It’s similar with multiple sclerosis. Actually, there are so many good drugs out there. A lot of the market has already been ...

Sima Sistani, CEO of WeightWatchers, announced her departure from the weight-loss company, which has struggled to adapt in ...

WeightWatchers CEO Sima Sistani, who pushed the beleaguered company into embracing weight loss drugs like Ozempic, is leaving ...

Sen. Bernie Sanders’ aggressive targeting of Danish drugmaker Novo Nordisk’s Ozempic and Wegovy pricing, and not Eli Lilly’s ...

Read Deep Dive: Commercialisation in full pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical ...

Compounding pharmacies have increasingly been at the centre of safety concerns around the legitimacy and credibility of ...

Biomea stock rises 9% after the FDA lifts clinical hold on two phase I/II studies evaluating the company's lead candidate, ...